Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

OBJECTIVE A high frequency of infections complicating rheumatoid arthritis (RA) has been described in reports of case series. This retrospective longitudinal cohort study was undertaken to compare the frequency of infections in a population-based incidence cohort of RA patients with that in a group of individuals without RA from the same population. METHODS RA patients included all members of an incidence cohort of Rochester, Minnesota residents ages >or=18 years who were first diagnosed as having RA between 1955 and 1994. One age- and sex-matched subject without RA was selected for each patient with RA. Study subjects were followed up by review of their entire medical record until death, migration from the area, or study end (January 1, 2000), and details of all documented infections, along with information on potential risk factors for infection, were recorded. Hazard ratios for infections were estimated using stratified Andersen-Gill proportional hazards models, with adjustment for potential confounders. RESULTS The 609 RA patients and 609 non-RA study subjects (mean age 58.0 years; 73.1% female) were followed up for a mean of 12.7 years and 15.0 years, respectively, reflecting higher mortality among the group with RA. Hazards ratios for objectively confirmed infections, infections requiring hospitalization, and any documented infection in patients with RA were 1.70 (95% confidence interval [95% CI] 1.42-2.03), 1.83 (95% CI 1.52-2.21), and 1.45 (95% CI 1.29-1.64), respectively, after adjustment for age, sex, smoking status, leukopenia, corticosteroid use, and diabetes mellitus. Sites of infection with the highest risk ratios were bone, joints, skin, soft tissues, and the respiratory tract. CONCLUSION In this study, patients with RA were at increased risk of developing infections compared with non-RA subjects. This may be due to immunomodulatory effects of RA, or to agents with immunosuppressive effects used in its treatment.

[1]  S. Gabriel,et al.  Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. , 2002, Arthritis and rheumatism.

[2]  E. Matteson,et al.  Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. , 2001, Mayo Clinic proceedings.

[3]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[4]  W. O'Fallon,et al.  T cell homeostasis in patients with rheumatoid arthritis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Alcocer-Varela,et al.  Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis. A nested case-control study. , 1998, The Journal of rheumatology.

[6]  M. Sneller,et al.  Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. , 1997, Rheumatic diseases clinics of North America.

[7]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[8]  H. Kautiainen,et al.  Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. , 1995, Clinical and experimental rheumatology.

[9]  D. Furst,et al.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. , 1994, The American journal of medicine.

[10]  A. Silman,et al.  Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. , 1990, Annals of the rheumatic diseases.

[11]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[12]  D. Goldenberg.  Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. , 1989, Arthritis and rheumatism.

[13]  A. Cats,et al.  Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. , 1988, Arthritis and rheumatism.

[14]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[15]  A. Cats,et al.  Frequency of infections among rheumatoid arthritis patients, before and after disease onset. , 1987, Arthritis and rheumatism.

[16]  M. Laakso,et al.  Ten year mortality and causes of death in patients with rheumatoid arthritis. , 1985, British medical journal.

[17]  D. Symmons,et al.  Cause of death in rheumatoid arthritis. , 1984, British journal of rheumatology.

[18]  L. Kurland,et al.  The patient record in epidemiology. , 1981, Scientific American.

[19]  R. Stevenson,et al.  Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. , 1976, The Journal of rheumatology.

[20]  E. Huskisson,et al.  Severe, unusual, and recurrent infections in rheumatoid arthritis. , 1972, Annals of the rheumatic diseases.

[21]  J. Baum.  Infection in rheumatoid arthritis. , 1971, Arthritis and rheumatism.

[22]  W. C. Walker.  Pulmonary infections and rheumatoid arthritis. , 1967, The Quarterly journal of medicine.

[23]  D. Rimoin,et al.  Acute septic arthritis complicating chronic rheumatoid arthritis. , 1966, JAMA.

[24]  David R. Cox,et al.  SOME SIMPLE APPROXIMATE TESTS FOR POISSON VARIATES , 1953 .